公司资料
Bicycle Therapeutics 股价、新闻与催化剂
- 股票代码:
- BCYC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom with U
股票表现
4.00 USD (+2.56%)
收盘价
最后更新: 2026年8月17日
300M USD
市值
股价为何变动
As of Aug 17, 2026, BCYC closed up 2.56% at $4.00. No new same-company headline was identified in the current news window.
公司概览
业务概览
Bicycle Therapeutics is a precision-oncology company focused on bicyclic peptide therapeutics and targeted cancer biology. Its platform seeks to pair selectivity with tumor targeting.
所在地与行业分类
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ as an ADR, Bicycle is a global oncology biotech.
商业模式特征
The company depends on clinical data, platform validation, and the possibility of building a differentiated targeted-cancer franchise.
生物医药行业定位
Bicycle is a high-quality platform oncology name whose valuation hinges on translational and clinical progress.
未来催化剂
- Bicycle Therapeutics's catalysts are BT8009 and BT5528, with oncology data driving whether the platform can still justify premium expectations. The next readout matters a lot because the platform story is still being judged.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。